MoonLake Immunotherapeutics
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Sep 2020 | $143.5K | $163.5K | — |
| Dec 2020 | $4.2M | $116.6M | $1.3M |
| Mar 2021 | — | — | $0 |
| Mar 2021 | $4.1M | $116.5M | $1.2M |
| Jun 2021 | $4.1M | $116.4M | $1.1M |
| Sep 2021 | $6.1M | $116.2M | $1.0M |
| Dec 2021 | $21.3M | $9.7M | $8.0M |
| Mar 2022 | $206.8M | $231.2M | $23.3K |
| Jun 2022 | $3.9M | $98.4M | $92.7M |
| Sep 2022 | $6.0M | $88.6M | $41.2M |
| Dec 2022 | $8.1M | $76.8M | $39.5M |
| Mar 2023 | $7.7M | $66.8M | $50.1M |
| Jun 2023 | $7.5M | $506.6M | $501.8M |
| Sep 2023 | $10.6M | $500.2M | $318.2M |
| Dec 2023 | $13.0M | $526.5M | $451.2M |
| Mar 2024 | $11.7M | $564.1M | $458.4M |
| Jun 2024 | $14.8M | $544.9M | $342.8M |
| Sep 2024 | $22.7M | $518.2M | $375.7M |
| Dec 2024 | $24.5M | $477.9M | $180.4M |
| Mar 2025 | $98.7M | $511.3M | $271.6M |
| Jun 2025 | $102.2M | $460.1M | $306.7M |
| Sep 2025 | $123.1M | $414.3M | $350.7M |
| Dec 2025 | $120.0M | $424.4M | $334.5M |
| Mar 2026 | $146.4M | $400.4M | $298.5M |
| Jun 2026 | $145.8M | $573.9M | $477.9M |